Dr. Nafee Tahmidul Talukder, DO

Dr. Talukder practices at Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health.

Dr. Talukder's NPI, 1225599640, was assigned on March 28, 2019. Dr. Talukder holds New Jersey license 25MB12065600.

Dr. Talukder's primary practice is Ocean University Medical Center, at 425 Jack Martin Blvd, Brick, NJ 08724 in Ocean County. The practice phone is (732) 840-2200.

Dr. Talukder's primary practice is Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health. Dr. Talukder is also affiliated with Hackensack University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Talukder to 4 more hospitals, 11 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Talukder practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Talukder's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Talukder's licenses on file in 2 states: New Jersey and New York.

CMS data shows 315 Medicare services from Dr. Talukder across 5 procedure codes in 2024, for 171 Medicare patients. Medicare paid $25,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Talukder in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Talukder's median patient age at 63, with 54% women.

In 2024, Dr. Talukder wrote 71 Medicare Part D claims for 16 patients. 83% of them were for generic drugs. CMS names the drug for 30 of them, across 1 drug with 11 or more claims each, at $567 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

Dr. Talukder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Talukder, published from 2021 to 2022. 2021 was the busiest year, with 2. Dr. Talukder has published most often in J Med Case Rep. Dr. Talukder's most frequent co-authors are Moira Black, MD, Daniel Lewis Cooke, MD and Guilherme Dabus, MD.

CMS Open Payments shows 16 general payments to Dr. Talukder from 7 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $148.